Compounders Research Compare

Oruka Therapeutics, Inc.(ORKA)

Biotechnology · Menlo Park, CA

$80.13-4.25 (-5.04%)

Delayed quote: Oct 6, 2026, 2:55 PM EDT

About Oruka Therapeutics, Inc.

Oruka Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing novel monoclonal antibody therapeutics for psoriasis (PsO), and other inflammatory and immunology (I&I) indications. Its lead products include ORKA-001 that targets p19 subunit of interleukin-23, which is in phase 2a trial for the treatment of PsO; and ORKA-002 that targets interleukin-17A and interleukin-17F, which is in phase 2 trial for the treatment of PsO, psoriatic arthritis, and other conditions. The company also develops ORKA-003 for targeting an undisclosed pathway; and ORKA-021, a sequential combination regimen of ORKA-002 and ORKA-001. Oruka Therapeutics, Inc. is headquartered in Menlo Park, California.

Menlo Park, CA

68 employees

www.orukatx.com

Healthcare / Biotechnology

Sector: Healthcare
Industry: Biotechnology
CEO: Lawrence Otto Klein

View full financials

Oruka Therapeutics (ORKA) Earnings Yield: History & Chart | TGMCharts

Earnings Yield: N/A

Basis: Unrounded diluted TTM EPS / FMP quote price × 100. Source: stored company filings and market data; unavailable inputs remain N/A.

The earnings yield is N/A as of 2026-10-06T18:58:07.122Z.

Stored calculation inputs

Calculation as of: 2026-10-06T18:58:07.122Z.

Quote observation: 2026-10-06T18:55:13.000Z. Amounts in USD. The price header may show a later quote.

Unrounded diluted TTM EPS · period ending 2026-06-30: -2.47
Quote price: 80.1283

FMP input reference: 0b6e81bfb968b053e3c664bae947515aab5c23e1d2a9854177de48c3869b2902

P/E Ratio|FCF Yield|Dividend Yield|All Metrics

ORKA Earnings Yield Metrics

EARNINGS YIELD

N/A

ORKA Competitors' Earnings Yield

Oruka Therapeutics, Inc.

Current

Market Cap

$4.83B

Earnings Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

Mirum Pharmaceuticals, Inc.

Market Cap

$4.78B

Earnings Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

Dianthus Therapeutics, Inc.

Market Cap

$4.75B

Earnings Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

Erasca, Inc.

Market Cap

$4.95B

Earnings Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

Definium Therapeutics, Inc.

Market Cap

$4.68B

Earnings Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

LifeStance Health Group, Inc.

Market Cap

$4.68B

Earnings Yield

1.07%

TTM Avg

0.64%

3Y Avg

0.64%

5Y Avg

0.64%

Waystar Holding Corp.

Market Cap

$5.01B

Earnings Yield

2.68%

TTM Avg

2.51%

3Y Avg

1.98%

5Y Avg

1.98%

Option Care Health, Inc.

Market Cap

$4.65B

Earnings Yield

4.28%

TTM Avg

4.92%

3Y Avg

4.57%

5Y Avg

3.88%

BillionToOne, Inc.

Market Cap

$4.65B

Earnings Yield

0.61%

TTM Avg

0.37%

3Y Avg

0.37%

5Y Avg

0.37%

Merit Medical Systems, Inc.

Market Cap

$5.05B

Earnings Yield

2.86%

TTM Avg

2.80%

3Y Avg

2.38%

5Y Avg

2.05%

NAME	MARKET CAP	EARNINGS YIELD	TTM	3Y	5Y
Oruka Therapeutics, Inc. (ORKA)	$4.83B	N/A	N/A	N/A	N/A
Mirum Pharmaceuticals, Inc. (MIRM)vs ›	$4.78B	N/A	N/A	N/A	N/A
Dianthus Therapeutics, Inc. (DNTH)vs ›	$4.75B	N/A	N/A	N/A	N/A
Erasca, Inc. (ERAS)vs ›	$4.95B	N/A	N/A	N/A	N/A
Definium Therapeutics, Inc. (DFTX)vs ›	$4.68B	N/A	N/A	N/A	N/A
LifeStance Health Group, Inc. (LFST)vs ›	$4.68B	1.07%	0.64%	0.64%	0.64%
Waystar Holding Corp. (WAY)vs ›	$5.01B	2.68%	2.51%	1.98%	1.98%
Option Care Health, Inc. (OPCH)vs ›	$4.65B	4.28%	4.92%	4.57%	3.88%
BillionToOne, Inc. (BLLN)vs ›	$4.65B	0.61%	0.37%	0.37%	0.37%
Merit Medical Systems, Inc. (MMSI)vs ›	$5.05B	2.86%	2.80%	2.38%	2.05%

Earnings Yield vs P/E Ratio

Earnings Yield

N/A

EPS ÷ Price

P/E Ratio

N/A

Price ÷ EPS

Formula: Earnings Yield = (EPS / Price) × 100

Earnings Yield is simply the inverse of P/E. A P/E of 20 equals a 5% earnings yield.

How earnings yield is used:

It expresses earnings relative to share price as a percentage
It can be compared with FCF yield and dividend yield
It can be compared with bond yields because both are percentages
It is mathematically the inverse of the P/E ratio

Earnings Yield Formula & Definition

Earnings Yield = EPS (TTM) / Share Price

Earnings yield is the inverse of the PE ratio, expressing trailing earnings as a percentage of price. Higher is cheaper.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

Related Metrics

P/E Ratio FCF Yield Dividend Yield All Metrics